Skip to content
Therapeutic Areas
Oncology
Gastroenterology (GI)
Hematology
Cell and Gene Therapy
Neurology
Infectious Diseases
Radiopharmaceuticals
Respiratory
Other TAs
Insights
Global Reach
About PSI
About Us
Newsroom
Careers
Therapeutic Areas
Oncology
Gastroenterology (GI)
Hematology
Cell and Gene Therapy
Neurology
Infectious Diseases
Radiopharmaceuticals
Respiratory
Other TAs
Insights
Global Reach
About PSI
About Us
Newsroom
Careers
Contact
Submit RFP
Search
Tag: Gastroenterology
Placebo response in IBD trials
Advances in IBD treatment considerations, GI trial design, and the impact of AI
Holistic care in IBD: Maturing from concept to practice
Managing enrollment and site performance in competitive upper GI trial programs
On-time enrollment of patients with celiac disease
Rescuing a global IBD trial: Speed is key
6 Applications of AI in GI
New EASL Guidelines Aim to Improve Diagnostic Accuracy and Outcomes for AIH Patients
Anti-TL1A Therapies: IBD Landscape Disrupted?
«
Page
1
Page
2
Page
3
»
Therapeutic Areas
Oncology
Gastroenterology (GI)
Hematology
Cell and Gene Therapy
Neurology
Infectious Diseases
Radiopharmaceuticals
Respiratory
Other Therapeutic Areas
Insights
Global Reach
VISIONAL™ by PSI
SYNETIC™ by PSI
Industry Events
Careers
About PSI
About Us
Newsroom
Contact Us
Submit RFP
New EASL Guidelines Aim to Improve Diagnostic Accuracy and Outcomes for AIH Patients